Partnership / Enterprise
Deep learning platform (AtomNet) for structure-based small molecule drug discovery. Screens trillions of compounds against disease targets. 250+ research partnerships.
Molecular databasesresearch lab platforms
Vendor detail
Owkin
Federated learning AI platform for biomedical research. Trains AI models on sensitive hospital data without compromising privacy. Focuses on oncology and patient stratification.
Vendor snapshot
Category
Drug Discovery & Research
Best for
Cancer centers, pharma companies
Pricing
Partnership / Enterprise
Pricing detail
Research partnerships; contact for pricing
Integrations
2 connected systems listed
Status
Unclaimed
Last checked
2026-03
Editorial review
This review is written by the directory and is kept separate from company-managed profile content.Federated learning is the right answer for healthcare — train on sensitive data without moving it. Owkin's privacy-preserving approach makes multi-institutional collaboration practical.
Pricing
- Research partnerships; contact for pricing
Integrations
Hospital EHR systemsgenomic databases
Explore more Drug Discovery & Research
Partnership / Enterprise
End-to-end AI drug discovery platform (Pharma.AI). One of the first companies to have an AI-designed drug enter human clinical trials. Focuses on oncology and fibrosis.
Lab automation systemsgenomic databases
Contact for Pricing
Genomics’ Mystra is an AI-enabled human genetics platform for drug target discovery and validation, offered with self-serve SaaS and managed options.
Partnership / Public Company
AI-first drug discovery company combining biological imaging, machine learning, and automated labs to identify therapeutic candidates at scale. Partnerships with Bayer and Roche.
Automated lab systemsgenomic databasescloud compute